A detailed history of Lafayette Investments, Inc. transactions in Pfizer Inc stock. As of the latest transaction made, Lafayette Investments, Inc. holds 20,199 shares of PFE stock, worth $532,445. This represents 0.12% of its overall portfolio holdings.

Number of Shares
20,199
Previous 20,299 0.49%
Holding current value
$532,445
Previous $567,000 3.0%
% of portfolio
0.12%
Previous 0.13%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 22, 2024

SELL
$27.7 - $31.39 $2,770 - $3,139
-100 Reduced 0.49%
20,199 $584,000
Q2 2024

Jul 31, 2024

BUY
$25.26 - $29.6 $69,490 - $81,429
2,751 Added 15.68%
20,299 $567,000
Q4 2023

Jan 31, 2024

BUY
$26.13 - $33.94 $2,038 - $2,647
78 Added 0.45%
17,548 $505,000
Q3 2023

Oct 27, 2023

BUY
$32.09 - $37.51 $11,809 - $13,803
368 Added 2.15%
17,470 $579,000
Q4 2021

Feb 10, 2022

SELL
$41.32 - $61.25 $4,958 - $7,350
-120 Reduced 0.7%
17,102 $1.01 Million
Q2 2021

Aug 10, 2021

BUY
$35.91 - $40.68 $12,676 - $14,360
353 Added 2.09%
17,222 $674,000
Q3 2020

Oct 30, 2020

BUY
$31.75 - $37.25 $12,858 - $15,086
405 Added 2.46%
16,869 $619,000
Q1 2020

May 07, 2020

SELL
$27.03 - $38.62 $3,513 - $5,020
-130 Reduced 0.78%
16,464 $537,000
Q3 2019

Oct 23, 2019

SELL
$32.49 - $42.13 $4,548 - $5,898
-140 Reduced 0.84%
16,594 $596,000
Q1 2019

May 03, 2019

SELL
$37.5 - $41.2 $20,550 - $22,577
-548 Reduced 3.17%
16,734 $711,000
Q4 2018

Feb 05, 2019

BUY
$38.47 - $43.86 $18,811 - $21,447
489 Added 2.91%
17,282 $754,000
Q3 2018

Nov 08, 2018

BUY
$34.47 - $41.81 $4,791 - $5,811
139 Added 0.83%
16,793 $740,000
Q1 2018

May 15, 2018

SELL
$31.91 - $37.02 $49,364 - $57,269
-1,547 Reduced 8.5%
16,654 $591,000
Q4 2017

Feb 12, 2018

SELL
$33.26 - $35.29 $45,067 - $47,817
-1,355 Reduced 6.93%
18,201 $659,000
Q3 2017

Nov 13, 2017

SELL
$31.0 - $34.15 $6,882 - $7,581
-222 Reduced 1.12%
19,556 $698,000
Q2 2017

Aug 14, 2017

BUY
N/A
19,778
19,778 $664,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $148B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Lafayette Investments, Inc. Portfolio

Follow Lafayette Investments, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lafayette Investments, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Lafayette Investments, Inc. with notifications on news.